Stockscreener 앱 받기
29.37
1.81%
-0.54
Assembly Biosciences Inc 주식(ASMB)의 최신 뉴스
Technical Analysis: What is Assembly Biosciences Incs 5 year growth outlookNew Guidance & Target Return Focused Stock Picks - baoquankhu1.vn
Returns Recap: Can Assembly Biosciences Inc disrupt its industryVolume Spike & Growth Oriented Trade Recommendations - baoquankhu1.vn
(ASMB) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Risks Report: What is the target price for Assembly Biosciences Inc stockTrade Performance Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Momentum Shift: How liquid is Assembly Biosciences Inc stockWeekly Profit Analysis & Community Trade Idea Sharing Platform - baoquankhu1.vn
Fed Meeting: Is Assembly Biosciences Inc benefiting from innovation trendsTrade Analysis Report & Consistent Profit Trading Strategies - baoquankhu1.vn
Exit Recap: Is Assembly Biosciences Inc impacted by rising ratesLayoff News & Smart Swing Trading Alerts - baoquankhu1.vn
Assembly Biosciences (ASMB) Sees Raised Price Target From Mizuho - GuruFocus
Gains Recap: What is the target price for Assembly Biosciences Inc stockEarnings Growth Report & High Accuracy Buy Signal Tips - baoquankhu1.vn
What are Assembly Biosciences Inc.’s earnings expectationsInsider Buying Signals & Free Real-Time Trading Alerts Every Day - bollywoodhelpline.com
Portfolio Recap: How Assembly Biosciences Inc stock reacts to inflationary pressures2025 Volatility Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Bull Run: Why Assembly Biosciences Inc V7B stock is a must watch tickerJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - Bộ Nội Vụ
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in ‘significantly de-risks’ genital herpes programs - MSN
Assembly Biosciences (ASMB) price target increased by 24.84% to 48.70 - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
How strong is Assembly Biosciences Inc. stock revenue growthWeekly Profit Recap & Precise Trade Entry Recommendations - ulpravda.ru
Aug Sectors: How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
Why Assembly Biosciences Inc. (V7B) stock is a must watch ticker2025 Stock Rankings & Consistent Growth Equity Picks - Улправда
Is Assembly Biosciences Inc. stock attractive after correction2025 AllTime Highs & Short-Term Trading Opportunity Alerts - Улправда
What risks investors should watch in Assembly Biosciences Inc. stockMarket Risk Analysis & Weekly High Conviction Ideas - Улправда
Why Assembly Biosciences Inc. stock remains a top recommendation2026 world cup usa national team third place match star players low block defense winner prediction guide - ulpravda.ru
(ASMB) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Stock Price Up 4% – Time to Buy? - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Trading 4% HigherHere's What Happened - MarketBeat
After 25 Years, Recurrent Genital Herpes Treatment Gains Corporate Partner - Vax-Before-Travel
Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for... - Medical Dialogues
Ellsworth Advisors LLC Acquires New Holdings in Assembly Biosciences, Inc. $ASMB - Defense World
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in 'significantly de-risks' genital herpes programs - MSN
Technical Reactions to ASMB Trends in Macro Strategies - Stock Traders Daily
With 32% ownership, Assembly Biosciences, Inc. (NASDAQ:ASMB) has piqued the interest of institutional investors - Yahoo Finance
Assembly Biosciences price target raised to $40 from $29 at Mizuho - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 6%What's Next? - MarketBeat
GILD Exercises Option to License Assembly Bio's Herpes Programs - WV News
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes - BioSpace
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Sahm
Assembly Biosciences (NASDAQ:ASMB) Receives Buy Rating from HC Wainwright - Defense World
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says HC Wainwright - MSN
Gilead exercises option for Assembly Bio’s herpes treatment programs By Investing.com - Investing.com South Africa
Gilead Sciences (GILD) Licenses Assembly Bio's Herpes Drug Progr - GuruFocus
HC Wainwright & Co. Reiterates Assembly Biosciences (ASMB) Buy Recommendation - Nasdaq
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs - Asianet Newsable
Assembly Biosciences (NASDAQ:ASMB) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Assembly Biosciences rises as Gilead opts to license co's HSV therapies - TradingView — Track All Markets
ASMB: HC Wainwright & Co. Reiterates Buy Rating with $50 PT | AS - GuruFocus
Gilead exercises license for Assembly Biosciences herpes programs - Seeking Alpha
Assembly Biosciences' (ASMB) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Program - PharmiWeb.com
Gilead pays $35M to license pair of HSV assets from Assembly Bio pact - Fierce Biotech
Assembly Biosciences (ASMB) Gains Momentum with Gilead Licensing Deal - GuruFocus
Gilead exercises option for Assembly Bio’s herpes treatment programs - Investing.com
Gilead exercises option for Assembly Bio's herpes treatment programs - StreetInsider
4.73%
0.92%
자본화:
|
볼륨(24시간):